MedPath

Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy

Phase 2
Terminated
Conditions
Renal Cell Carcinoma
Partial Nephrectomy
Interventions
Procedure: Hypoperfusion of renal artery
Registration Number
NCT01720693
Lead Sponsor
University Health Network, Toronto
Brief Summary

Many patients who are candidates for nephron-sparing surgery, partial nephrectomy is now the standard treatment with a surgical, small, clinical T1 tumor (\<7 cm). In many recent studies, partial nephrectomy provides equivalent oncologic, and superior functional, outcomes compared with the standard radical nephrectomy over the short and long term (2, 3). Partial nephrectomy techniques, whether open, laparoscopic or robotic, typically involve hilar clamping, which creates the desired bloodless operative field, allowing for more precise tumor excision and renal reconstruction. This hilar clamping eventually may lead to ischemic kidney injury which can compromise the functional outcomes of the remaining kidney.We are working now to develop a novel technique of Hypo-Perfusion by achieving partial renal arterial clamping, with the goal of completely eliminating surgical ischemia to the renal remnant.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Patient must be at least 18 years old scheduled for open partial nephrectomy
Read More
Exclusion Criteria
  • No prior diagnosis of renal artery disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
hypoperfusionHypoperfusion of renal arteryHypoperfusion of the renal artery
Primary Outcome Measures
NameTimeMethod
To perfect the Renal Hypoperfusion during partial nephrectomy is feasible safe and result in better renal function than complete occlusion of renal blood flowup to 2 weeks prior to surgery and up to 24 hrs post surgery

renal function will be measured using creatinine, eGFR, 24 hr creat clearance, and NGAL biomarker of acute kidney injury

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Health Network

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath